To further confirm that tissue-inappropriate expression of IRX3 contributes functionally to the differentiation block in AML, we performed knockdown (KD) experiments in human THP1 AML cells, which exhibit the highest levels of IRX3 expression among AML cell lines we tested (Figure S4A). This evidence concerns the gene IRX3 and acute myeloid leukemia.